Key Statisticslimited data
Market Cap$126.95B
P/E RatioN/A
Div. Yield—
EPS (TTM)$3.88
52W High—
52W Low—
SectorHealth Care
Industry—
Employees32,500
Price Performance
1 Week+1.81%
3 Month+12.33%
1 Year+3.08%
FinancialsAnnual · QuiverQuant
Revenue$45.01B
Assets$95.16B
Liabilities$65.67B
Net Income$8.04B
About
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
Company Info
WebullFree stocks
Advanced charting, extended hours trading, and free stock for new accounts.
Analyze BMY with professional charts— Free to start
Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.